Every material Form 8-K Lifevantage Corp has filed with the SEC since May 06, 2026, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
LifeVantage reported fourth-quarter and full fiscal 2026 results (year ended June 30, 2026) showing sharp declines in revenue and profit from the prior year. The company is not issuing formal fiscal 2027 guidance because of the recent transition in its Chief Executive Officer role, leaving shareholders without a company forecast for the coming year.
Fiscal 2026 revenue was $182.6 million, down 20.1% from $228.5 million in fiscal 2025; Americas revenue fell 23.2%.
Fourth-quarter revenue was $42.4 million, down 23.1%, and diluted EPS was $0.10 versus $0.15 a year earlier.
Fiscal 2026 diluted EPS was $0.40 versus $0.75; adjusted EPS was $0.56 versus $0.82.
No formal fiscal 2027 guidance was issued due to the recent CEO transition; Terrence Moorehead is President and CEO.
LifeVantage's Board approved a 2026 New Employee Long-Term Incentive Plan on July 31, 2026, without stockholder approval under Nasdaq Rule 5635(c)(4). The plan reserves 1,500,000 common shares for awards that may only go to new hires or rehires after a bona fide non-employment period, as an inducement to join the company.
Board approved the 2026 New Employee Plan on July 31, 2026.
1,500,000 shares of common stock initially reserved for awards under the plan.
Adopted without stockholder approval under Nasdaq Listing Rule 5635(c)(4); incentive stock options are not permitted.
Full plan terms are filed as Exhibit 10.1 to the 8-K.
LifeVantage reported third-quarter fiscal 2026 revenue of $43.7 million, down 25.2% from a year earlier, with diluted earnings per share of $0.11 versus $0.26. The company now expects fiscal 2026 revenue, adjusted EBITDA and adjusted EPS to be close to the lower end of its previously issued guidance range, which weighs on shareholders' outlook.
Q3 revenue was $43.7 million versus $58.4 million a year earlier, down 25.2%; Americas revenue fell 28.9%.
Net income per diluted share was $0.11 versus $0.26; adjusted EBITDA was $3.2 million versus $6.4 million.
Fiscal 2026 revenue, adjusted EBITDA and adjusted EPS are expected close to the lower end of prior guidance.
Quarterly cash dividend declared at $0.05 per share, up from $0.045, payable June 15, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Lifevantage Corp filing is on SEC EDGAR ↗. 8-K briefs of other companies →